Advocacy – HKAPI

29 一月 26

2026 粵港澳大灣區真實世界研究論壇

本會與粵港澳大灣區國際臨床試驗所及其主要設施真實世界研究及應用中心合辦的「2026 粵港澳大灣區真實世界研究論壇」，匯聚來自海外、中國內地及大灣區（包括香港）的政府代表、學術界權威、醫療機構代表及藥業界領袖等，共同探討真實世界研究如何推動未來醫療發展。

29 九月 25

Policy Address 2025: Government Policy Briefing for HKAPI Members

HKAPI hosted an exclusive policy briefing for its members with presentations from officials of the Health Bureau, Department of Health, Hospital Authority, and GBAICTI. The briefing highlighted key initiatives from the recent Policy Address impacting the pharmaceutical industry

26 八月 25

Preserving Trust: AI and Data Privacy in Healthcare

On 26 August 2025, the Hong Kong Association of the Pharmaceutical Industry (HKAPI) and Cyberport co-hosted “Preserving Trust: AI and Data Privacy in Healthcare” at Cyberport. The event brought together experts from healthcare, technology, academia, and data governance to explore how Artificial Intelligence (AI) is reshaping healthcare while ensuring patient privacy and public trust.

15 八月 25

CEO Meeting: Understanding the IMACE & Policy Address

On 15 August 2025, the HKAPI hosted its 4th CEO Meeting of the 2024–2026 term, bringing together General Managers, CEOs, and Directors from 15 member companies.

12 二月 25

Visiting GBAICTI: Paving the Way for Cross-Boundary Clinical Trials

On 12 February 2025, around 30 delegates from 20 member companies visited GBAICTI and HTCZ.

24 八月 24

HKAPI Supports Primary Healthcare Development Through Health Day Event

We are delighted to announce our collaboration with the HKU LKS Faculty of Medicine's Department of Pharmacology and Pharmacy, the Jockey Club PHARM+ Community Medication Service Network, the Sha Tin District Health Centre Express, and our Associate Member, Chinachem Group, to organize a health day event for the elderly residents of Golden Lion Garden.

13 十月 23

本會會員參與廣東省藥品醫療器械創新發展論壇

香港科研製藥聯會高級執行董事陳素娟女士，代表本會參與其中一場圓桌討論。

16 二月 23

HKAPI x HKSTP – How AI is Transforming Drug Discovery and Clinical Trial Design

The "Symposium - How AI is Transforming Drug Discovery and Clinical Trial Design" was a huge success, with drug developers and investors in attendance to learn about the latest AI technologies in drug discovery and clinical development.